Clinical trial reportOphthalmology. RetinaPublished
TALON Phase IIIb Study: 32-Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age-Related Macular Degeneration
Regional connection
Verified Author affiliations on the Europe PMC record name Thomas Jefferson University, Wills Eye Hospital. Affiliation source
- Institutions
- Thomas Jefferson University, Wills Eye Hospital
- County
- Philadelphia County
Publication record
- Type
- Clinical trial report
- Venue
- Ophthalmology. Retina
- Published
- Topic
- Clinical care
- Subject terms
- Fundus Oculi; Macula Lutea; Humans; Receptors, Vascular Endothelial Growth Factor; Angiogenesis Inhibitors; Recombinant Fusion Proteins; Tomography, Optical Coherence; Fluorescein Angiography; Treatment Outcome; Follow-Up Studies; Double-Blind Method; Visual Acuity
- PubMed ID
- 40466770
- Added to directory
- Source checked